Institutions / SUPERSTRING CAPITAL MANAGEMENT LP / Holdings
Back to SUPERSTRING CAPITAL MANAGEMENT LP

Superstring Capital Management LP

All holdings · as of Dec 31, 2025

45 positions

CompanyClassValueShares% of portfolio
CIDARA THERAPEUTICS INC—$18.80M85,09810.1%
Terns Pharmaceuticals, Inc.—$17.93M443,7779.6%
UROGEN PHARMA LTD—$16.82M718,3549.0%
Cogent Biosciences, Inc.—$13.01M366,2387.0%
DYNAVAX TECHNOLOGIES CORP—$8.08M525,5924.3%
Sionna Therapeutics, Inc.—$7.43M180,5934.0%
Immunovant, Inc.IMVTCommon Stock$7.34M288,6773.9%
Axsome Therapeutics, Inc.—$6.84M37,4333.7%
Savara IncSVRACommon Stock$6.00M995,3533.2%
MIND MEDICINE MINDMED INC—$5.69M425,2023.0%
Taysha Gene Therapies, Inc.TSHACommon Stock$5.39M980,7682.9%
Ocular Therapeutix, Inc—$5.08M418,0802.7%
AMICUS THERAPEUTICS INC—$5.03M352,8962.7%
Cabaletta Bio, Inc.—$4.94M2,253,5502.6%
United Therapeutics Corp—$4.61M9,4512.5%
Revolution Medicines, Inc.—$4.37M54,8792.3%
BELITE BIO, INCBLTEADR$3.95M24,7032.1%
BRIGHT MINDS BIOSCIENCES INC.—$3.69M47,2782.0%
Zai Lab Limited—$3.47M196,8531.9%
Zenas BioPharma, Inc.ZBIOCommon Stock$3.03M83,3531.6%
QUINCE THERAPEUTICS INC—$2.88M858,7111.5%
Avalo Therapeutics, Inc.—$2.78M153,3131.5%
CAPRICOR THERAPEUTICS, INC.—$2.78M96,3341.5%
PALVELLA THERAPEUTICS, INC.PVLACommon Stock$2.67M25,4691.4%
Celldex Therapeutics, Inc.—$2.40M88,3081.3%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$2.22M65,2731.2%
Oric Pharmaceuticals, Inc.—$2.09M255,3701.1%
Protara Therapeutics, Inc.—$1.92M360,0001.0%
Trevi Therapeutics, Inc.—$1.86M148,2921.0%
Tyra Biosciences, Inc.—$1.54M58,6770.8%
Travere Therapeutics, Inc.—$1.45M38,0220.8%
Viridian Therapeutics, Inc.—$1.35M43,2300.7%
Rezolute, Inc.—$1.21M513,7650.6%
Dianthus Therapeutics, Inc.—$1.08M26,2490.6%
SPRUCE BIOSCIENCES, INC.SPRBCommon Stock$1.06M12,1370.6%
Aardvark Therapeutics, Inc.AARDCommon Stock$912.1K69,4960.5%
GENMAB A/S—$898.2K29,1620.5%
PALISADE BIO, INC.—$862.7K367,1030.5%
Fulcrum Therapeutics, Inc.—$815.0K72,0600.4%
Ultragenyx Pharmaceutical Inc.—$730.0K31,7380.4%
Palatin Technologies, Inc.PTNCommon Stock$522.5K33,9710.3%
INVENTIVA SA—$465.0K100,0000.2%
Century Therapeutics, Inc.IPSCCommon Stock$460.6K462,9630.2%
Biomea Fusion, Inc.BMEACommon Stock$310.0K250,0000.2%
ENTERA BIO LTD—$33.3K17,1420.0%
← PrevPage 1 of 1Next →